TY - JOUR
T1 - Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city
AU - Footer, Katherine H.A.
AU - Lim, Sahnah
AU - Rael, Christine Tagliaferri
AU - Greene, George J.
AU - Carballa-Diéguez, Alex
AU - Giguere, Rebecca
AU - Martinez, Michelle
AU - Bockting, Walter
AU - D’Aquila, Richard
AU - Sherman, Susan G.
N1 - Funding Information:
The Sustained Long-Acting Protection Against HIV (SLAP HIV) study was funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health Award number: UM1AI120184; PI Patrick Kiser and Thomas Hope. We gratefully acknowledge our study participants and staff from the SAPPHIRE study, in particular Erin Wingo, as well as the Baltimore Needle Exchange Program, BCHD. The Sustained Long-Acting Protection Against HIV (SLAP HIV) study was funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health Award number: UM1AI120184; PI Patrick Kiser and Thomas Hope.
Funding Information:
We gratefully acknowledge our study participants and staff from the SAPPHIRE study, in particular Erin Wingo, as well as the Baltimore Needle Exchange Program, BCHD. The Sustained Long-Acting Protection Against HIV (SLAP HIV) study was funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health Award number: UM1AI120184; PI Patrick Kiser and Thomas Hope.
Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/10/3
Y1 - 2019/10/3
N2 - To address a shortage in research on Pre-Exposure Prophylaxis (PrEP) amongst women at high risk of HIV acquisition, this study explored the attitudes and preferences of female sex workers (FSW) (n = 15) and women who inject drugs (WWID) (n = 16) to existing (e.g., pill) and new (e.g., injection, implant) PrEP modalities, in Baltimore, Maryland, U.S.A. This study reports on seven focus groups conducted between December 2016 and April 2017 and aims to provide new insights into FSW and WWID attitudes and preferences towards three different PrEP delivery methods (i.e., PrEP pill, PrEP implant, PrEP injection). Results draw upon the PrEP care continuum framework and distill existing factors, including lack of control over side effects with new, longer lasting modalities, better privacy with injections, increased adherence with reduced dosing schedules from longer lasting PrEP and new factors such as perceptibility concerns with respect to the PrEP implant relevant to PrEP uptake and adherence among two important overlapping, at-risk populations. The study contributes to a better understanding of barriers and facilitators to uptake and adherence for FSW and WWID around both existing and new PrEP modalities, with implications for future clinical trials and PrEP interventions with at risk-populations.
AB - To address a shortage in research on Pre-Exposure Prophylaxis (PrEP) amongst women at high risk of HIV acquisition, this study explored the attitudes and preferences of female sex workers (FSW) (n = 15) and women who inject drugs (WWID) (n = 16) to existing (e.g., pill) and new (e.g., injection, implant) PrEP modalities, in Baltimore, Maryland, U.S.A. This study reports on seven focus groups conducted between December 2016 and April 2017 and aims to provide new insights into FSW and WWID attitudes and preferences towards three different PrEP delivery methods (i.e., PrEP pill, PrEP implant, PrEP injection). Results draw upon the PrEP care continuum framework and distill existing factors, including lack of control over side effects with new, longer lasting modalities, better privacy with injections, increased adherence with reduced dosing schedules from longer lasting PrEP and new factors such as perceptibility concerns with respect to the PrEP implant relevant to PrEP uptake and adherence among two important overlapping, at-risk populations. The study contributes to a better understanding of barriers and facilitators to uptake and adherence for FSW and WWID around both existing and new PrEP modalities, with implications for future clinical trials and PrEP interventions with at risk-populations.
KW - HIV
KW - Modes of delivery
KW - PrEP
KW - female injection drug user
KW - female sex worker
UR - http://www.scopus.com/inward/record.url?scp=85062439711&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062439711&partnerID=8YFLogxK
U2 - 10.1080/09540121.2019.1587352
DO - 10.1080/09540121.2019.1587352
M3 - Article
C2 - 30822101
AN - SCOPUS:85062439711
SN - 0954-0121
VL - 31
SP - 1207
EP - 1213
JO - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
JF - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
IS - 10
ER -
